Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolomics-guided discovery of previously undescribed lupane-type triterpenoids with anti-inflammatory activity from Mallotus repandus (Willd.) Müll. Arg.

Phytochemistry·2026
Same author

Genomic and plasmid profiles of multidrug-resistant <i>Salmonella</i> isolates from pediatric patients from Zhuhai, China.

Microbiology spectrum·2026
Same author

Elucidation of population-based bacterial adaptation to antimicrobial treatment by single-cell sequencing analysis of the gut microbiome of a hospital patient.

mSystems·2025
Same author

Genetic Risk of Different Populations in COVID-19 Susceptibility and Severity.

Infection and drug resistance·2025
Same author

Community gut colonization by <i>tet</i>(X4)-positive multidrug-resistant <i>Escherichia coli</i> in healthy individuals from urban residents in Shenzhen, China.

Frontiers in cellular and infection microbiology·2025
Same author

Harnessing mRNA-encoded PcrV-targeting monoclonal antibodies for combating antibiotic-resistant P. aeruginosa infections.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Related Experiment Video

Updated: May 8, 2026

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
15:05

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons

Published on: February 5, 2015

Engineering Clostridia Neurotoxins with elevated catalytic activity.

Jiubiao Guo1, Xuehua Pan, Yanxiang Zhao

  • 1Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong Special Administrative Region.

Toxicon : Official Journal of the International Society on Toxinology
|September 3, 2013
PubMed
Summary

Researchers engineered botulinum neurotoxin type B (BoNT/B) and tetanus neurotoxin (TeNT) variants with enhanced activity. These modified toxins offer improved tools for studying neuronal exocytosis and potential new therapies for BoNT/B resistance.

Keywords:
BoNT/BBotulinum NeurotoxinBotulinum Neurotoxin BCNTsClostridia NeurotoxinsElevated activityEngineeringLCLight chainSNARETeNTTetanus NeurotoxinVAMP2light chainsoluble NSF attachment receptorvesicle associated membrane protein-2

More Related Videos

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

Related Experiment Videos

Last Updated: May 8, 2026

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
15:05

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons

Published on: February 5, 2015

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Botulinum neurotoxin type B (BoNT/B) and tetanus neurotoxin (TeNT) cleave the VAMP2 substrate at the same bond.
  • Differences in their hydrolysis efficiency and substrate recognition suggest variations in their active site pockets.

Purpose of the Study:

  • To investigate the role of substrate recognition pockets in the differing activities of BoNT/B and TeNT.
  • To engineer enhanced activity variants of these neurotoxins for research and therapeutic applications.

Main Methods:

  • Site-directed mutagenesis was employed to swap key residues within the S1' and S1 pockets of the light chains (LC) of BoNT/B and TeNT.
  • Activity assays were performed to quantify the hydrolysis efficiency of the engineered toxin variants.

Main Results:

  • Swapping the LC/T S1' pocket residue L(230) with isoleucine from LC/B increased LC/T activity ~25-fold.
  • Swapping the LC/B S1' pocket residue S(201) with proline from LC/T increased LC/B activity ~10-fold.
  • Optimizing both S1 and S1' pocket residues in LC/T (K(168)E, L(230)I) resulted in over a 100-fold increase in activity.

Conclusions:

  • Specific residue substitutions in the active site pockets significantly modulate the catalytic activity of BoNT/B and TeNT.
  • Engineered LC/T variants with high activity can serve as improved tools for studying exocytosis mechanisms.
  • Enhanced LC/B variants may offer therapeutic potential against BoNT/B immunoresistance.